InCarda CEO, Grace Colón, Discusses InRhythm™ Program and Unmet Needs for Atrial Fibrillation at Biotech Showcase 2020
InCarda Therapeutics CEO Grace Colón, PhD, meets with CG Life Managing Partner Erik Clausen at Biotech Showcase 2020 to discuss unmet needs in cardiovascular health. She provides an update on the company’s development of first-of-their-kind inhaled therapies for cardiovascular diseases, including atrial fibrillation. Dr. Colón...